Page last updated: 2024-11-12

2-(4-chlorophenyl)-1,2-benzothiazol-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11219195
CHEMBL ID98386
CHEBI ID92921
SCHEMBL ID2537846

Synonyms (17)

Synonym
CHEMBL98386
KUC103658N
MLS-0390874.0001 ,
MLS003116053 ,
smr001831608
kuc103658
KUC103658N-02
ksc-325-055
2-(4-chlorophenyl)-1,2-benzothiazol-3-one
cid_11219195
bdbm46691
SCHEMBL2537846
CHEBI:92921
2-(4-chlorophenyl)-1,2-benzisothiazol-3(2h)-one
Q27164663
2620-91-9
2-(4-chlorophenyl)benzo[d]isothiazol-3(2h)-one

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The most promising compounds were also profiled for bioavailability parameters, including metabolic stability, plasma stability, and permeability."( Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.
Bravo, Y; Brown, B; Cosford, ND; Dahl, R; Dhanya, RP; Freeze, HH; Hedrick, M; Ichikawa, M; Mangravita-Novo, A; Rascon, J; Sergienko, E; Sharma, V; Smith, LH; Stonich, D; Su, Y; Vicchiarelli, M; Yang, L, 2011
)
0.37

Dosage Studied

ExcerptRelevanceReference
" The pharmacokinetic profile of a representative of this series (compound 19; ML089) was also assessed, demonstrating the potential of this series for in vivo efficacy when dosed orally in disease models."( Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.
Bravo, Y; Brown, B; Cosford, ND; Dahl, R; Dhanya, RP; Freeze, HH; Hedrick, M; Ichikawa, M; Mangravita-Novo, A; Rascon, J; Sergienko, E; Sharma, V; Smith, LH; Stonich, D; Su, Y; Vicchiarelli, M; Yang, L, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzothiazoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nrf2Homo sapiens (human)Potency17.78280.09208.222223.1093AID624171
glp-1 receptor, partialHomo sapiens (human)Potency8.91250.01846.806014.1254AID624417
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency1.94760.000811.382244.6684AID686978; AID686979
Smad3Homo sapiens (human)Potency17.78280.00527.809829.0929AID588855
hypothetical protein, conservedTrypanosoma bruceiPotency31.62280.223911.245135.4813AID624173
67.9K proteinVaccinia virusPotency10.00000.00018.4406100.0000AID720580
IDH1Homo sapiens (human)Potency18.35640.005210.865235.4813AID686970
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency44.66843.548119.542744.6684AID743266
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency2.99350.168316.404067.0158AID720504
VprHuman immunodeficiency virus 1Potency8.91251.584919.626463.0957AID651644
Glycoprotein hormones alpha chainHomo sapiens (human)Potency14.12544.46688.344810.0000AID624291
Alpha-synucleinHomo sapiens (human)Potency31.62280.56239.398525.1189AID652106
TAR DNA-binding protein 43Homo sapiens (human)Potency5.62341.778316.208135.4813AID652104
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency44.66843.981146.7448112.2020AID720708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
MPI proteinHomo sapiens (human)IC50 (µMol)2.45000.190013.825650.1000AID1535
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonasePlasmodium bergheiIC50 (µMol)12.37670.889021.028671.5000AID504765; AID540252; AID540269
hexokinaseTrypanosoma brucei brucei TREU927IC50 (µMol)1.10000.20084.602422.3780AID2230
phosphomannomutase 2Homo sapiens (human)IC50 (µMol)35.60000.672034.783897.3000AID1655
glucose-6-phosphate 1-dehydrogenase isoform bHomo sapiens (human)IC50 (µMol)10.50008.870012.851817.8000AID504792
rac GTPase-activating protein 1 isoform aHomo sapiens (human)IC50 (µMol)2.35700.69020.81450.9388AID652153
rac GTPase-activating protein 1 isoform aHomo sapiens (human)IC50 (µMol)34.69007.390057.8904301.2400AID624330
Phosphomannomutase 2Homo sapiens (human)IC50 (µMol)20.00005.20005.20005.2000AID597375
Neutrophil elastaseHomo sapiens (human)IC50 (µMol)1.10000.00632.073422.3780AID2230
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)0.39000.00402.92669.9600AID1805801
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)0.39000.00022.45859.9600AID1805801
Mannose-6-phosphate isomeraseHomo sapiens (human)IC50 (µMol)1.90000.71003.31756.4000AID597374
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (145)

Processvia Protein(s)Taxonomy
protein glycosylationPhosphomannomutase 2Homo sapiens (human)
GDP-mannose biosynthetic processPhosphomannomutase 2Homo sapiens (human)
protein N-linked glycosylationPhosphomannomutase 2Homo sapiens (human)
mannose metabolic processPhosphomannomutase 2Homo sapiens (human)
G protein-coupled receptor signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell population proliferationGlycoprotein hormones alpha chainHomo sapiens (human)
hormone-mediated signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
regulation of signaling receptor activityGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of steroid biosynthetic processGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell migrationGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid gland developmentGlycoprotein hormones alpha chainHomo sapiens (human)
luteinizing hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlycoprotein hormones alpha chainHomo sapiens (human)
negative regulation of organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid hormone generationGlycoprotein hormones alpha chainHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINeutrophil elastaseHomo sapiens (human)
response to yeastNeutrophil elastaseHomo sapiens (human)
leukocyte migration involved in inflammatory responseNeutrophil elastaseHomo sapiens (human)
biosynthetic process of antibacterial peptides active against Gram-negative bacteriaNeutrophil elastaseHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
intracellular calcium ion homeostasisNeutrophil elastaseHomo sapiens (human)
response to UVNeutrophil elastaseHomo sapiens (human)
extracellular matrix disassemblyNeutrophil elastaseHomo sapiens (human)
protein catabolic processNeutrophil elastaseHomo sapiens (human)
response to lipopolysaccharideNeutrophil elastaseHomo sapiens (human)
negative regulation of chemokine productionNeutrophil elastaseHomo sapiens (human)
negative regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
positive regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
defense response to bacteriumNeutrophil elastaseHomo sapiens (human)
positive regulation of MAP kinase activityNeutrophil elastaseHomo sapiens (human)
positive regulation of smooth muscle cell proliferationNeutrophil elastaseHomo sapiens (human)
negative regulation of inflammatory responseNeutrophil elastaseHomo sapiens (human)
positive regulation of immune responseNeutrophil elastaseHomo sapiens (human)
negative regulation of chemotaxisNeutrophil elastaseHomo sapiens (human)
pyroptosisNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of fungusNeutrophil elastaseHomo sapiens (human)
positive regulation of leukocyte tethering or rollingNeutrophil elastaseHomo sapiens (human)
phagocytosisNeutrophil elastaseHomo sapiens (human)
acute inflammatory response to antigenic stimulusNeutrophil elastaseHomo sapiens (human)
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
GDP-mannose biosynthetic processMannose-6-phosphate isomeraseHomo sapiens (human)
mannose to fructose-6-phosphate catabolic processMannose-6-phosphate isomeraseHomo sapiens (human)
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (61)

Processvia Protein(s)Taxonomy
phosphomannomutase activityPhosphomannomutase 2Homo sapiens (human)
protein bindingPhosphomannomutase 2Homo sapiens (human)
metal ion bindingPhosphomannomutase 2Homo sapiens (human)
hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
protein bindingGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
protease bindingNeutrophil elastaseHomo sapiens (human)
transcription corepressor activityNeutrophil elastaseHomo sapiens (human)
endopeptidase activityNeutrophil elastaseHomo sapiens (human)
serine-type endopeptidase activityNeutrophil elastaseHomo sapiens (human)
protein bindingNeutrophil elastaseHomo sapiens (human)
heparin bindingNeutrophil elastaseHomo sapiens (human)
peptidase activityNeutrophil elastaseHomo sapiens (human)
cytokine bindingNeutrophil elastaseHomo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mannose-6-phosphate isomerase activityMannose-6-phosphate isomeraseHomo sapiens (human)
zinc ion bindingMannose-6-phosphate isomeraseHomo sapiens (human)
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (42)

Processvia Protein(s)Taxonomy
nucleoplasmPhosphomannomutase 2Homo sapiens (human)
cytosolPhosphomannomutase 2Homo sapiens (human)
neuronal cell bodyPhosphomannomutase 2Homo sapiens (human)
cytosolPhosphomannomutase 2Homo sapiens (human)
extracellular regionGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
Golgi lumenGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone complexGlycoprotein hormones alpha chainHomo sapiens (human)
pituitary gonadotropin complexGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular regionNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
cytoplasmNeutrophil elastaseHomo sapiens (human)
cytosolNeutrophil elastaseHomo sapiens (human)
cell surfaceNeutrophil elastaseHomo sapiens (human)
secretory granuleNeutrophil elastaseHomo sapiens (human)
azurophil granule lumenNeutrophil elastaseHomo sapiens (human)
specific granule lumenNeutrophil elastaseHomo sapiens (human)
phagocytic vesicleNeutrophil elastaseHomo sapiens (human)
collagen-containing extracellular matrixNeutrophil elastaseHomo sapiens (human)
extracellular exosomeNeutrophil elastaseHomo sapiens (human)
transcription repressor complexNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cytosolMannose-6-phosphate isomeraseHomo sapiens (human)
extracellular exosomeMannose-6-phosphate isomeraseHomo sapiens (human)
cytosolMannose-6-phosphate isomeraseHomo sapiens (human)
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (65)

Assay IDTitleYearJournalArticle
AID1324739Antibacterial activity against methicillin-resistant Staphylococcus aureus NRS77 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430055Anti-fungal activity against Aspergillus fumigatus after 48 hrs by broth microdilution method
AID1324721Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430054Anti-fungal activity against Trichophyton mentagrophytes after 48 hrs by broth microdilution method
AID597375Inhibition of human purified PMM22011Journal of medicinal chemistry, May-26, Volume: 54, Issue:10
Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.
AID1324749Antibacterial activity against Enterococcus faecalis ATCC 29212 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430052Anti-fungal activity against Cryptococcus neoformans after 48 hrs by broth microdilution method
AID1324736Antibacterial activity against methicillin-resistant Staphylococcus aureus G14 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID597374Inhibition of human purified phosphomannose isomerase2011Journal of medicinal chemistry, May-26, Volume: 54, Issue:10
Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.
AID1324742Antibacterial activity against methicillin-resistant Staphylococcus aureus S22 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324740Antibacterial activity against methicillin-resistant Staphylococcus aureus S14 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324743Antibacterial activity against methicillin-resistant Staphylococcus aureus S24 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430053Anti-fungal activity against Sporothrix schenckii after 48 hrs by broth microdilution method
AID1324725Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430047Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method
AID1430057Antibacterial activity against gentamicin-resistant Staphylococcus aureus ATCC 33592 by broth microdilution method
AID1430059Cytotoxicity against monkey Vero C1008 cells after 72 hrs by MTT assay
AID1430056Anti-fungal activity against Candida parapsilosis ATCC 22019 after 48 hrs by broth microdilution method
AID1324732Antibacterial activity against methicillin-resistant Staphylococcus aureus C19 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324729Antibacterial activity against methicillin-resistant Staphylococcus aureus C7 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324733Antibacterial activity against methicillin-resistant Staphylococcus aureus G1 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324752Antibacterial activity against Vancomycin-resistant Enterococcus measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324751Antibacterial activity against Enterococcus faecium BM4105-RF measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430049Antibacterial activity against Pseudomonas aeruginosa ATCC BAA-427 by broth microdilution method
AID1430058Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by SYBR Green-1 staining based fluorescence assay
AID1324726Antibacterial activity against methicillin-resistant Staphylococcus aureus BRS3 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430051Anti-fungal activity against Candida albicans after 48 hrs by broth microdilution method
AID1324728Antibacterial activity against methicillin-resistant Staphylococcus aureus C2 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324720Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 6538 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324727Antibacterial activity against methicillin-resistant Staphylococcus aureus C1 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430045Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method
AID1430048Antibacterial activity against Escherichia coli ATCC 9637 by broth microdilution method
AID1324750Antibacterial activity against Enterococcus faecalis ATCC 49533 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430050Antibacterial activity against Klebsiella pneumoniae ATCC 27736 by broth microdilution method
AID1324746Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324745Antibacterial activity against methicillin-resistant Staphylococcus aureus USA200 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324737Antibacterial activity against methicillin-resistant Staphylococcus aureus NRS4 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324754Antibacterial activity against Mycobacterium smegmatis MC2-155 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324744Antibacterial activity against methicillin-resistant Staphylococcus aureus USA100 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324741Antibacterial activity against methicillin-resistant Staphylococcus aureus S17 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324730Antibacterial activity against methicillin-resistant Staphylococcus aureus C14 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430046Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 by broth microdilution method
AID1324734Antibacterial activity against methicillin-resistant Staphylococcus aureus G6 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324748Antibacterial activity against Staphylococcus epidermidis ATCC 35984 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324753Antibacterial activity against Listeria monocytogenes ATCC 19115 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324724Antibacterial activity against methicillin-resistant Staphylococcus aureus 1 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1430060Selectivity index, ratio of CC50 for monkey Vero C1008 cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D7
AID1324722Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324747Antibacterial activity against methicillin-resistant Staphylococcus aureus USA600 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324735Antibacterial activity against methicillin-resistant Staphylococcus aureus G12 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324723Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324738Antibacterial activity against methicillin-resistant Staphylococcus aureus NRS51 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID1324731Antibacterial activity against methicillin-resistant Staphylococcus aureus C16 measured after overnight incubation by broth double-dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1805801Various Assay from Article 10.1021/acs.jmedchem.1c00409: \\Perspectives on SARS-CoV-2 Main Protease Inhibitors.\\2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.39 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]